Skip to main content
. 2021 Sep 16;45:18–24. doi: 10.1016/j.athplu.2021.09.004

Table 2.

Association between remnant cholesterol and cardiovascular disease in young and later adults.

Outcomes
Remnant cholesterol, mmol/L
Per 1 mmol/L increase
P for trend
Pinteraction
<0.50
0.50–0.99
1.00–1.49
≥1.50
Age<40 years
Case, n (%) 33(0.58) 39(0.91) 35(1.17) 57(1.73)
Incidence rate, per 1000 person-y 0.53(0.38–0.75) 0.84(0.61–1.15) 1.08(0.77–1.50) 1.60(1.23–2.07)
Model 1 Reference 1.49(0.94–2.37) 1.91(1.18–3.07) 2.48(1.61–3.81) 1.26(1.12–1.41) <0.0001 0.0004
Model 2 Reference 1.46(0.92–2.33) 1.85(1.14–2.99) 2.24(1.45–3.47) 1.23(1.09–1.39) <0.0001 0.0019
Age≥40 years
Case, n (%) 1454(7.33) 1351(7.31) 1131(7.19) 2145(8.46)
Incidence rate, per 1000 person-y 7.18(6.82–7.56) 7.14(6.76–7.53) 6.99(6.60–7.41) 8.26(7.92–8.62)
Model 1 Reference 1.01(0.94–1.09) 0.99(0.92–1.07) 1.22(1.14–1.30) 1.06(1.04–1.08) <0.0001
Model 2 Reference 0.98(0.91–1.06) 1.00(0.92–1.08) 1.21(1.13–1.29) 1.06(1.03–1.09) <0.0001

Model 1: adjusted for age and sex.

Model 2: further adjusted for body mass index, systolic blood pressure, diastolic blood pressure, education, income, smoking status, drinking status, physical activity, a history of hypertension, diabetes mellitus, and dyslipidemia, antihypertensive drugs, antidiabetic drugs, fasting blood glucose, and high sensitivity C-reactive protein.